Alvaro Moreira

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

Alvaro Moreira, Carmen Loquai, Claudia Pföhler et al. · European Journal of Cancer · 2018 · 226 citations

Autoimmune Disease, Immune Checkpoint Inhibitors, Immune Regulation +6

Eosinophilic Count as a Biomarker for Prognosis of Melanoma Patients and Its Importance in The Response to Immunotherapy

Alvaro Moreira, Waltraud Leisgang, Gerold Schuler et al. · Immunotherapy · 2017 · 144 citations

Hematological immune related adverse events after treatment with immune checkpoint inhibitors

Rafaela Kramer, Anne Zaremba, Alvaro Moreira et al. · European Journal of Cancer · 2021 · 84 citations

Hematological Malignancy, Autoimmune Disease, Immune Checkpoint Inhibitors +8

Senescence markers: Predictive for response to checkpoint inhibitors

Alvaro Moreira, Michael Constantin Kirchberger, Michael Erdmann et al. · International Journal of Cancer · 2018 · 53 citations · Full text

Aging, Immunology, Immunoediting +16

Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients

Michael Constantin Kirchberger, Alvaro Moreira, Michael Erdmann et al. · Oncotarget · 2018 · 45 citations · Full text